Donald Budenz, MD
Enriched profileProfessor of Ophthalmology and Medical Director, Bascom Palmer Eye Institute at SoLe Mia · University of Miami Health System
Donald Budenz is Professor of Ophthalmology and Medical Director, Bascom Palmer Eye Institute at SoLe Mia at University of Miami Health System. OpenAlex indexes 378 publications with 26,811 citations (h-index 79); ClinicalTrials.gov lists 4 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Ophthalmology profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Donald L. Budenz, MD, is Professor of Ophthalmology and Medical Director, Bascom Palmer Eye Institute at SoLe Mia at University of Miami Health System / Bascom Palmer Eye Institute. The public record shows 378 publications with 26,811 citations (h-index 79), centered on Glaucoma. It also documents an investigator role on 4 registered clinical trials, industry payments reported by 6 companies, 2 NIH-funded awards (1996–2011).
- Most recent indexed publication: 2015 · The British journal of ophthalmology
- Top research focus: Glaucoma
- 4 registered trials on ClinicalTrials.gov
- Open Payments reporting from 6 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 1 in PubMed.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 4 registered studies on ClinicalTrials.gov. The most recent:
- The Ghana Primary Tube Versus Trabeculectomy Study
Sponsor: Tema Christian Eye Center
- Incidence and Progression of Glaucoma in the Tema Eye Survey Cohort
Sponsor: Tema Christian Eye Center
- Macular Ganglion Cell Analysis (GCA) of the Cirrus HD-OCT in Glaucoma
Sponsor: Carl Zeiss Meditec, Inc.
Industry payments
Updated 27 Aug 2026
6 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Alcon Research LLCProgram year20251 payment
- Glaukos CorporationProgram year20231 payment
- Carl Zeiss Meditec, Inc.Program year20221 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
85.8%Corticosteroid28.1%Prednisolone Acetate100%Part D≥203 patientsProstaglandin Analog24.9%Latanoprost89%Lumigan6%Travoprost5%Part D<11 patientsMusculoskeletal
9.5%Cyclooxygenase Inhibitor9.5%Ketorolac Tromethamine100%Part D≥70 patientsCardiovascular
4.8%Beta blocker4.8%Timolol Maleate100%Part D≥20 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
2 NIH research awards on record, funded 1996–2011 per NIH RePORTER. The latest:
- Peripapillary Atrophy Progression During The Ocular Hypertension Treatment Study
University of Miami School of Medicine
FY2011$92,301R21EY019954 - Peripapillary Atrophy Progression During The Ocular Hypertension Treatment Study
Univ of North Carolina Chapel Hill
FY2011$91,223R21EY019954 - Peripapillary Atrophy Progression During The Ocular Hypertension Treatment Study
University of Miami School of Medicine
FY2010$218,783R21EY019954
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Retinal nerve fibre layer thickness floor and corresponding functional loss in glaucoma.
The British journal of ophthalmology
Article2015
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Other
independent.academia.edu/DonaldBudenz
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →independent.academia.edu ↗ - ResearchGate
researchgate.net/lab/Lab-Donald-L-Budenz
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →researchgate.net ↗
Mentions by others
where others cite or feature them- Other
doctors.umiamihealth.org/provider/donald-l-budenz/5885835
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doctors.umiamihealth.org ↗ - Other
aao.org/about/awards/humanitarian/donald-budenz
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doctors.umiamihealth.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doctors.umiamihealth.org ↗
- Board Certified
American Board of Ophthalmology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doctors.umiamihealth.org ↗ - Ophthalmology residency
Scheie Eye Institute, University of Pennsylvania
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →www3.pennmedicine.org ↗ - Glaucoma fellowship (Heed Foundation)
Bascom Palmer Eye Institute, University of Miami
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →www3.pennmedicine.org ↗
Editorial & leadership roles
journal and society appointments- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.unc.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.unc.edu ↗
- Principal Investigator
Ocular Hypertension Treatment Study (OHTS), Tube Versus Trabeculectomy (TVT) Study, and Ahmed Baerveldt Comparison (ABC) Study, landmark multicenter glaucoma clinical trials
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →www3.pennmedicine.org ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.unc.edu ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →news.unchealthcare.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.unc.edu ↗
Secondary affiliations
appointments beyond the home institution- Immediate past Chair and Kittner Family Distinguished Professor of Ophthalmology
University of North Carolina at Chapel Hill School of Medicine (chaired dept. 2011-2025; stepped down effective ~Nov 1 …
2025verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.unc.edu ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →glaucomatoday.com ↗
- "Donald Budenz Recognized as 'World Expert' in Glaucoma"
UNC Health newsroom feature
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →news.unchealthcare.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Eduardo Alfonso, MD
University of Miami Health System
Craig McKeown, MD
University of Miami Health System
Hilda Capo, MD
University of Miami Health System
Gene Burkett, MD
University of Miami Health System